Vaso-Occulsive Crisis: The Future of Treating Patients with Sickle Cell Disease in Emergency DepartmentsDecember 29th 2022
"The challenge right now is that we have no therapies in the emergency department to treat acute pain, outside of pain medications and IV opioids," Dr. Claudia Morris says in an interview.
From Early Hypothesis to Clinical Data About Reducing Vaso-Occlusive Episodes with Arginine TherapyDecember 22nd 2022
Almost 25 years later, Dr. Claudia Morris concluded 2022 by presenting phase 2 data at the 64th ASH Annual Meeting that demonstrated the therapy's benefit, and her original premise. Her team's phase 3 trial evaluating Arg is currently underway.
ASH 2022 Data Support Peer-Mediated Pain Management Groups for Patients with Sickle Cell DiseaseDecember 14th 2022
Expert Stephanie Guarino, MD, MSHP, shares her plan for the future of pain management specifically for sickle cell disease is based on results from a series of studies.
Corinna Schultz, MD: Does Sickle Cell Trait get Addressed?December 12th 2022
"There's no national guidance on how this information should be delivered back to families, which leaves it up to each state's newborn screening program to decide the best route that they see fit," Dr. Corinna Schultz explains.